Literature: open-access stability study

Gabapentin 100 mg/mL oral suspension

Ingredients

IngredientRoleFor 100 mL
Gabapentinactive10 g
Oral Mix or Oral Mix SF suspending vehiclevehicleq.s. to 100 mL
Strength
100 mg/mL
Starting material
Bulk powder or capsule contents
Container
Amber plastic bottles and amber plastic oral syringes
  • Crystallization occurred at 5 °C: do not refrigerate.

Amounts are ClinDose's arithmetic from the study's concentration; follow the study for the method.

Storage and beyond-use date

StorageBUDBasis
Room temperature90 daysCited stability study. Duration supported by the cited stability study for this formula, container, and storage.

Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.

Ingredient checks

No FDA compounding list or NIOSH flags for the active ingredient.

Source

Friciu M, Roullin VG, Leclair G. Stability of gabapentin in extemporaneously compounded oral suspensions. PLoS One. 2017;12(4):e0175208. PMID 28414771. PMC5393583. License: CC BY (checked 2026-11-06). Read the article · DOI

For licensed clinicians. Use with clinical judgment.